Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Renocontin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Renocontin 10mg modified-release tablets
0407020ADBRABAF
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 346 |
|
Renocontin 20mg modified-release tablets
0407020ADBRADAG
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 286 |
|
Renocontin 5mg modified-release tablets
0407020ADBRAAAK
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 155 |
|
Renocontin 40mg modified-release tablets
0407020ADBRAFAH
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 129 |
|
Renocontin 30mg modified-release tablets
0407020ADBRAEAR
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 127 |
|
Renocontin 15mg modified-release tablets
0407020ADBRACAS
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 87 |
|
Renocontin 60mg modified-release tablets
0407020ADBRAGAQ
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 46 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.